OGN vs SLGN · P/E 3.4, rev $3.02B vs P/E 14, rev $3.20B
Organon & Co (OGN) versus Silgan Holdings Inc (SLGN) — a side-by-side from cached financials, not a winner call.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Silgan Holdings Inc (SLGN) is a packaging & containers company listed on US.
Latest reported OGN revenue for 2026-06-30 was $3.02B. Net income was $254.0M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Latest reported SLGN revenue for 2026-06-30 was $3.20B. Net income was $138.8M. SLGN currently screens at market cap $3.83B and trailing P/E 13.6.
OGN currently screens at market cap $2.52B and trailing P/E 3.4. SLGN currently screens at market cap $3.83B and trailing P/E 13.6.
Not investment advice. Open the OGN and SLGN stock pages for the full models.
Not investment advice.